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Cell shapeThe membrane-permeabilizing activities of mastoparans and related histamine-releasing agents were
compared through measurements of K+ efﬂux from bacteria, erythrocytes, and mast cells. Changes in
bacterial cell viability, hemolysis, and histamine release, as well as in the shape of erythrocytes were also
investigated. The compounds tested were mastoparans (HR1, a mastoparan from Polistes jadwagae, and a
mastoparan from Vespula lewisii), granuliberin R, mast cell-degranulating peptide, and compound 48/80, as
well as antimicrobial peptides, such as magainin I, magainin II, gramicidin S, and melittin. We used a K+-
selective electrode to determine changes in the permeability to K+ of the cytoplasmic membranes of cells.
Consistent with the surface of mast cells becoming negatively charged during histamine release, due to the
translocation of phosphatidylserine to the outer leaﬂet of the cytoplasmic membrane, histamine-releasing
agents induced K+ efﬂux from mast cells, dependent on their ability to increase the permeability of bacterial
cytoplasmic membranes rich in negatively charged phospholipids. The present results demonstrated that
amphiphilic peptides, possessing both histamine-releasing and antimicrobial capabilities, induced the
permeabilization of the cytoplasmic membranes of not only bacteria but mast cells. Mastoparans increased
the permeability of membranes in human erythrocytes at higher concentrations, and changed the normal
discoid shape to a crenated form. The structural requirement for making the crenated form was determined
using compound 48/80 and its constituents (monomer, dimer, and trimer), changing systematically the
number of cationic charges of the molecules.+81 86 2517926.
atsu).
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Amphiphilic peptides can interact with membrane phospholipids,
independently of speciﬁc receptors, in a rapid and concentration-
dependent way [1–9]. These peptides generally form a cationic
amphiphilic secondary structure, with hydrophobic and cationic
amino acid residues in opposite directions, and therefore, can interact
with membrane lipids through both electrostatic and hydrophobic
interactions. The bacterial cytoplasmic membrane presents an
outermost leaﬂet rich in negatively charged phospholipids, while
the external face of mammalian cells is predominantly composed of
zwitterionic phospholipids. Besides the zwitterionic lipids, the
mammalian cells have high concentrations of cholesterol, which
acts to stabilize the bilayer. The lipid composition of the cell
membrane has been shown to be of paramount importance to the
selectivity of the permeabilization activity. An important feature of
amphiphilic peptides showing antimicrobial activity is positively
charged residues distributed along the peptide chain, serving togenerate an amphiphilic structure. The presence of these charged
groups generally renders the peptide more active against bacteria.
Moreover, due to weak interaction with zwitterionic lipids and
cholesterol, most of the peptides act weakly on mammalian cells.
In the present study, we were particularly interested in the
inﬂuences of mastoparans and related histamine-releasing reagents
on the permeability of the cytoplasmic membrane of mast cells,
compared with the membranes of bacterial cells and erythrocytes.
Mastoparans and many cationic substances activate rat peritoneal
mast cells, leading to the rapid release of histamine by exocytosis
[10–12]. These agents trigger mast cell exocytosis by directly
activating G proteins that control exocytosis [13–16], and hence, the
secretion of histamine generally proceeds without changes to the
permeability of the plasma membrane of mast cells. In secretory cells,
however, the transbilayer movement of an anionic phospholipid from
the inner to outer leaﬂet of the plasma membrane is known to occur
during platelet activation and exocytotic release from mast cells
[17–19]. Thus, it was speculated that mastoparans, which act weakly
on mammalian cells but strongly on bacterial cells, may enhance
permeabilization in mast cells, because the surface of mast cells
becomes negatively charged during histamine release, due to the
translocation of phosphatidylserine to the outer leaﬂet of the
cytoplasmic membrane [19].
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Fig. 1. Structure of (a) compound 48/80 and its components; (b) monomer, (c) dimer,
and (d) trimer.
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membrane dependence in detail, we compared the membrane-
permeabilizing activities of various mast cell-degranulating peptides
and antimicrobial peptides using three different types of cells; rat
peritoneal mast cells, human erythrocytes, and Staphylococcus aureus
cells. The compounds tested included mastoparans (such as HR1 from
the giant hornet Vespa orientalis [20], mastoparan from Polistes
jadwagae [11], and mastoparan from Vespula lewisii [10,11,21]),
granuliberin R [22], mast cell-degranulating peptide [23], and a
synthetic histamine liberator, compound 48/80 [24,25], as well as
antimicrobial peptides, such as magainin I [26], magainin II [26],
gramicidin S [27–29], and melittin [28,29]. The sequences of peptides
and the structure of compound 48/80 and its constituents are shown
in Table 1 and Fig. 1, respectively. They all possess a cationic
amphiphilic structure. We used a K+-selective electrode to monitor
changes in the permeability of the cytoplasmic membrane of cells.
Because the internal ionic environment of bacterial and mammalian
cells is generally rich in K+, leakage of this ion has been used to
monitor membranolytic events in various cell systems [21,27,29,30].
We present here for the ﬁrst time evidence that amphiphilic peptides,
possessing both histamine-releasing and antimicrobial capabilities,
enhanced the permeability to K+ of not only bacteria but mast cells.
Although mastoparans, like many amphiphilic peptides tested
in this study, acted weakly on erythrocyte membranes, we were
particularly interested in the morphological changes of human
erythrocytes induced by the peptides, having previously observed
that amphiphilic peptides, melittin and gramicidin S, caused changes
in the normal discoid shape of human erythrocytes to produce a
crenated form at the concentrations causing the change in perme-
ability [29]. Such a direct observation of morphological change
seemed to provide signiﬁcant information on the mechanism of
action of amphiphilic compounds. The barrel-stave and carpet models
have been proposed to explain the permeabilization of membranes by
amphiphilic peptides [1–8]. In the barrel-stave model, peptide
monomers associate and form a bundle of helices embedded in the
membrane, forming a transmembrane channel. In the carpet-like
model, the peptides cover the membrane like a carpet and remain
there with their hydrophobic surface facing the membrane and their
hydrophilic surface facing the solvent. According to this model, the
bilayer is destroyed by the formation of toroidal pores, micelles, and
vesicles. After the treatment of human erythrocytes with mastopar-
ans, changes from a normal discoid to crenated form were observed,
showing the accumulation of the peptides at the outer surface of the
membrane. This ﬁnding supported that mastoparans increased the
permeability of the erythrocyte membrane as proposed by the carpet
model [4,31]. The structural requirement for making the crenated
formwas further investigatedwith the use of compound 48/80 and its
constituents (monomer, dimer, and trimer) [32], changing systemat-Table 1
Peptides used.
Peptide Sequencea
HR1 I-N-L-K-A-I-A-A-L-V-K-K-V-L-NH2
Polistes mastoparan V-D-W-K-K-I-G-Q-H-I-L-S-V-L-NH2
Vespulamastoparan I-N-L-K-A-L-A-A-L-A-K-K-I-L-NH2
Granuliberin R F-G-F-L-P-I-Y-R-R-P-A-S-NH2
MCD peptide I-K-C-N-C-K-R-H-V-I-K-P-H-I-C-R-K-I-C-G-K-N-NH2
Magainin I G-I-G-K-F-L-H-S-A-G-K-F-G-K-A-F-V-G-E-I-M-K-S
Magainin II G-I-G-K-F-L-H-S-A-K-K-F-G-K-A-F-V-G-E-I-M-N-S
Melittin G-I-G-A-V-L-K-V-L-T-T-G-L-P-A-L-I-S-W-I-K-R-K-R-Q-Q-NH2
Gramicidin S cyclo(VOLFdPVOLFdP)
a Amino acids are labeled according to the one-letter codewith the following additions:
O=ornithine, Fd=D-phenylalanine. Block letters indicate basic and acidic amino acids.
Acidic amino acids, aspartic acid (D) and glutamic acid (E), contained in Polistes
mastoparan and magainins, respectively. Disulﬁde linkages are shown by solid lines.ically the number of cationic charges of the molecules. Compound 48/
80 is a polycationic polymer prepared by condensation of p-methoxy-
N-methylphenethylamine and formaldehyde, and the most active
polymer is the hexamer [24,25], as shown in Fig. 1.
2. Materials and methods
2.1. Reagents
The sources of reagents were as follows: mastoparan HR1 (named
mast cell-degranulating peptide HR1 in the Sigma catalog), masto-
paran from Polistes jadwagae (hereafter, Polistes mastoparan), mast
cell-degranulating peptide (MCD peptide), granuliberin R, gramicidin
S, melittin, magainin I, magainin II, compound 48/80, and valinomycin
from Sigma (St. Louis, MO); mastoparan from Vespula lewisii (Vespula
mastoparan) from Peptide Institute (Osaka, Japan); dioctyl phthalate
from Tokyo Kasei (Tokyo, Japan); and poly(vinyl chloride) (PVC)
(degree of polymerization, 1020) from Nacalai Tesque (Kyoto, Japan).
The monomer, dimer, and trimer of compound 48/80 were prepared
as reported previously [32]. All other materials were of analytical
reagent grade.
2.2. Electrode system
The K+-selective electrode was constructed using a PVC-based
membrane as reported previously [30,33]. The PVC membrane had the
following composition: 1 mg of valinomycin, 60 μl (about 60 mg) of
dioctyl phthalate, and 30 mg of PVC. The materials were dissolved in
tetrahydrofuran (about1 ml) andpoured into aﬂat Petri dish (28 mmin
diameter). Then, the solvent was evaporated off at room temperature.
The resultingmembranewas excised and attached to a PVC tube (4 mm
in outer diameter and 3 mm in inner diameter) with tetrahydrofuran
adhesive. The PVC tube was ﬁlled with 10 mM KCl, and the sensor
membrane was conditioned overnight. The electrochemical arrange-
ment was Ag, AgCl/10 mM KCl/sensor membrane/sample solution/1 M
NH4NO3 (salt bridge)/10 mM KCl/Ag, AgCl. The electromotive force
(emf) between the silver/silver chloride electrodes was measured
using a voltmeter with high input impedance produced by a ﬁeld-
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Sunnyvale, CA; input resistance N1012Ω) and was recorded.
2.3. Bacteria and erythrocytes
S. aureus FDA209P cellswere grownat 37 °C in amediumcontaining
1.5% polypeptone, 0.5% bovine extract, 0.5% NaCl, and 0.5% K2HPO4 [27].
The cells were harvested in an exponential phase of growth, washed
twice with buffer (100 mM choline chloride and 50 mM 4-morpholi-
nepropanesulphonic acid (Mops)–Tris, pH 7.2), and suspended in this
buffer at 5×109 cells/ml (0.6 mg cell protein/ml). Protein content was
determined by the method of Lowry et al. [34]. Human erythrocytes
were suspended in 0.15 M NaCl and 5 mM 4-(2-hydroxyethyl)-1-
peperazineethanesulphonic acid (Hepes)–NaOH (pH 7.4) at 1% hemat-
ocrit of 1×108 cells/ml. Cells were incubated with reagent at 37 °C for
30 min, and the amount of K+ efﬂuxed was measured with a K+-
selective electrode [29]. The total amount of K+ was determined by
disrupting cells withmelittin [29]. The viability of cells was determined
by counting colonies, and hemolysis was estimated by measuring the
absorbance at 540 nm [29].
2.4. Mast cells
Mast cells were collected from the peritoneal cavities of male
Wistar rats (300–350 g) and puriﬁed using Percoll as reported
previously [35]. The mast cells were suspended in a K+-free buffer
comprising 0.154 M NaCl, 0.9 mM CaCl2, 5.6 mM glucose, 0.01%
bovine serum albumin, and 5 mM Hepes–NaOH (pH 7.4) at
8×105 cells/ml. Because a great deal of spontaneous efﬂux of K+
was observed at 37 °C, this experiment was carried out at a lower
temperature, 20 °C. We monitored the time course of the efﬂux from
mast cells in situ to avoid any experimental error arising from a
spontaneous efﬂux, minimizing the difference in electric potential of
the K+-selective electrode before and after addition of the reagent.
Furthermore, we measured the efﬂux of K+ from mast cells by
increasing the cell concentration to 8×105 cells/ml, using a miniatur-
izedmeasuring system. Thismade the results more reliable, compared
with the previous study [21]. Speciﬁcally, the K+ and histamine assays
proceeded as follows. The K+ and reference electrodes were
immersed in a mast cell suspension (200 μl), and the suspension
was constantly stirred with a stirrer bar. The electrode system was
compact [30], and therefore, as little as 200 μl could be measured.
After the change in potential resulting from K+ efﬂux was recorded
for 5 min, 50 μl of the cell suspension was pipetted to analyze
histamine release, and melittin (ﬁnal concentration, 50 μM) was
added to the remaining cell suspension to determine the total amount
of K+ in mast cells. The amount of histamine was determined
ﬂuorometrically after conversion to the ﬂuorescent product by a
reaction with o-phthalaldehyde as reported [36].
2.5. Morphological observations
Cells were ﬁxed with 2% glutaraldehyde dissolved in 1/30 M
NaH2PO4/Na2HPO4 (pH 7.4) and observed under an optical micro-
scope connected to a monitor [37,38]. Shape changes were quantiﬁed
using the morphological indices deﬁned by Fujii and co-workers [39].
3. Results
3.1. K+ permeability measurements using mast cells
Permeability measurements using a K+-selective electrode are
widely performed using bacteria and erythrocytes, as well as artiﬁcial
liposomes [27,29,30,33,40–43]. In this study, we applied the electrode
tomast cells. Because the difference in the electric potential of the K+-
selective electrode before and after the addition of reagents wasrelatively small, wemonitored the time course of the efﬂux of K+ from
mast cells in situ. Fig. 2a shows the calibration graph for the K+
electrode in a K+-free buffer comprising 0.154 M NaCl, 0.9 mM CaCl2,
5.6 mM glucose, 0.01% bovine serum albumin, and 5 mM Hepes–
NaOH (pH 7.4). Fig. 2b shows the effect of HR1 on the efﬂux frommast
cells. Addition of the cell suspension produced an increase in the K+
concentration, which was attributed to the K+ remaining in the cell
suspension. Addition of HR1 (10 μM) induced an increase in the K+
concentration with a short time lag. Finally, a high concentration of
melittin (50 μM) was added to disrupt the membrane of mast cells, in
order to determine the total amount of K+ contained in the cells. Thus,
it was calculated that HR1 (10 μM) induced 48% efﬂux within 5 min
from the calibration graph shown in Fig. 2a. Such direct monitoring
presented unambiguous evidence of the efﬂux of K+ from mast cells.
Furthermore, the fact that the efﬂux of K+ began to increase shortly
after addition of HR1 correlated with the time-required release of
histamine [44] accompanying the translocation of phosphatidylserine
to the outer leaﬂet of the cytoplasmic membrane.
3.2. K+ efﬂux, cell viability, hemolysis, and histamine release
Fig. 3 shows HR1-induced K+ efﬂux, cell viability, hemolysis, and
histamine release in S. aureus cells, erythrocytes, and mast cells. As
shown in Fig. 3a, this peptide lowered theviabilityof S. aureus cells at the
concentrations causing changes in permeability to K+, indicating that
the antimicrobial activity of HR1 was the result of increasedmembrane
permeability, as in the case of many antimicrobial peptides [1–9]. This
peptide also caused the efﬂux of K+ from erythrocytes and hemolysis at
higher concentrations. The weak activity against mammalian cells is a
general characteristic of amphiphilic peptides [1–9]. An interesting
feature is that the concentrations required for the efﬂux frommast cells
were signiﬁcantly lower than those usedwith erythrocytes. This ismost
probably because the surface of mast cells became negatively charged
during the secretion of histamine, due to the translocation of
phosphatidylserine to the outer leaﬂet of the cytoplasmic membrane
of mast cells [19], making the peptide susceptible to mast cells, as
mentioned in the Introduction. Furthermore, HR1 induced K+ efﬂux
from mast cells immediately after liberating histamine. This indicated
that HR1 had the ability to interact with negatively charged lipids on
mast cells, in accordancewith the strong effect on bacterial membranes
rich in anionic lipids, as shown in Fig. 3a. Similar results were obtained
with Polistesmastoparan and Vespulamastoparan. Table 2 summarizes
ED50 values (concentrations giving 50% K+ efﬂux, cell viability,
hemolysis, or histamine release) for these mastoparan groups, along
with the results for related histamine-releasing agents mentioned later.
Next, we examined the effects of granuliberin R (Fig. 4). This
peptide, isolated from frog skin, has been reported to liberate
histamine from rat peritoneal mast cells [22], though no study has
reported antimicrobial activity. In fact, granuliberin acted very weakly
on S. aureus cells, while it induced the release of histamine from mast
cells near the concentration range of HR1. No remarkable K+ efﬂux
from erythrocytes or hemolysis was observed. Interestingly, the efﬂux
from mast cells occurred close to the concentration range causing K+
efﬂux from S. aureus cells, though at very high concentrations. This
ﬁnding seemed to support the view that the peptide acted on anionic
lipids of not only bacterial cells but mast cells that appeared during
histamine secretion, though the concentrations needed to permeabi-
lize membranes were very high. MCD peptide [23], a potent histamine
liberator found in bee venom, did not remarkably induce K+ efﬂux
from mast cells, consistent with the absence of antimicrobial activity
at the concentrations tested. The ED50 values (the concentrations
giving 50% K+ efﬂux, cell viability, hemolysis, and histamine release)
for granuliberin R and MCD peptide are summarized in Table 2.
Fig. 5 shows the results for compound 48/80. This compound is
known to effectively liberate histamine via a selective and noncytotoxic
action [45], and also to act as a weak antimicrobial agent [46,47].
Fig. 2. (a) Calibration graph for the K+-selective electrode in a K+-free buffer comprising 0.154 M NaCl, 0.9 mM CaCl2, 5.6 mM glucose, 0.01% bovine serum albumin, and 5 mM
Hepes–NaOH (pH 7.4). (b) The efﬂux of K+ from mast cells induced by HR1. The mast cell suspension (30 μl, ﬁnal cell concentration of 8×105 cells/ml) was added to 170 μl of the
K+-free buffer at 20 °C at the time indicated by the ﬁrst arrow. The second arrow indicates when 1 μl of 2 mMHR1 (ﬁnal concentration, 10 μM)was added. The third arrow indicates
when melittin (ﬁnal concentration, 50 μM) was added to disrupt the cytoplasmic membrane of mast cells to determine the total amount of K+ in the cells.
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low concentrations, and reduced the viability of S. aureus cells at
relatively high concentrations. Compound 48/80 decreased the viability
of S. aureus cells concomitantly with the efﬂux of K+, showing that the
antimicrobial activity was attributable to the increased permeability
of the bacterial cytoplasmic membrane. The efﬂux from mast cells
was induced at a much lower concentration range than that from
erythrocytes, and rather near to the concentrations required for K+Fig. 3. The dose–response graphs of K+ efﬂux (○), cell viability (●), hemolysis (×), and
histamine release (▲) in (a) S. aureus cells, (b) erythrocytes, and (c) mast cells induced
by HR1. S. aureus cells were suspended in 100 mM choline chloride and 50 mM Mops–
Tris (pH 7.2) at 5×109 cells/ml. Human erythrocytes were suspended in 0.15 M NaCl
and 5 mM Hepes–NaOH (pH 7.4) at 1×108 cells/ml. Mast cells were suspended in a
K+-free buffer solution comprising 0.154 M NaCl, 0.9 mM CaCl2, 5.6 mM glucose, 0.01%
bovine serum albumin, and 5 mM Hepes–NaOH (pH 7.4) at 8×105 cells/ml. S. aureus
cells and erythrocytes were incubated with HR1 at 37 °C for 30 min. The amounts of K+
and histamine released from mast cells were determined after cells were incubated
with HR1 at 20 °C for 5 min.efﬂux from S. aureus cells, also indicating the susceptibility of the
histamine-releasing agent to negatively charged membranes.
The same experiments were performed using various membrane-
active peptides; magainin I, magainin II, gramicidin S, and melittin.
Table 2 summarizes ED50 values for all substances tested in this study.
In general, there was a tendency for the amphiphilic peptides, with
both histamine-releasing and antimicrobial capabilities, to induce the
permeabilization of the cytoplasmic membranes of not only bacteria
but mast cells.
3.3. Morphological changes in human erythrocytes
Fig. 6 shows mastoparan-induced morphological changes in
human erythrocytes at the concentrations causing hemolysis (about
20–30%). All the mastoparans caused a change from the normal
discoid shape to a crenated form, as in the case of gramicidin S and
melittin reported previously [29]. The crenated cells increased with
increasing concentrations of the peptides.
Changes in the shape of human erythrocytes induced by
amphiphilic compounds are generally discussed based on the bilayer
couple hypothesis proposed by Sheetz and Singer [48]. According to
this hypothesis, cell shape is strongly dependent on the charge of the
amphiphiles. Negatively charged amphiphiles caused discoid cells to
adopt a crenated form named echinocytes, while positively charged
amphiphiles with proper lipophilicity generated an invaginated form
named stomatocytes. Anionic amphiphiles that produce echinocytes
associated mostly with the outer monolayer of the erythrocyte
membrane, as a result of their inability to cross the bilayer, or because
of repulsion by a negatively charged phosphatidylserine located in the
inner monolayer of the erythrocyte membrane [49]. Conversely,
cationic amphiphiles that induced stomatocytes did so by partitioning
selectively into the cell inner monolayer, through association with an
inner anionic lipid. However, the cationic compounds, whose rates of
transmembrane movement were slow, made the erythrocytes
crenated [39,50]. The mastoparans tested in this study changed the
shape to that of echinocytes. These peptides had several basic amino
acids, such as lysine, and also acidic amino acid, such as aspartic acid,
in Polistesmastoparan,making it strongly hydrophilic, and hence, they
had difﬁcultly crossing the lipid interior, causing selective accumu-
lation in the outer monolayer, leading to the formation of echinocytes.
To obtain further insight into the dependence of changes in cell shape
on the number of cationic charges, we used compound 48/80 and its
components (monomer, dimer, and trimer). Dialysis and gel ﬁltration
[24] and NMR studies [25] have shown that themost active polymer is
Table 2
ED50 values (concentrations giving 50% K+ efﬂux, cell viability, hemolysis and histamine release) of mastoparans and related histamine-releasing compounds. a
S. aureus cells Human erythrocytes Rat peritoneal mast cells
K+ efﬂux Cell viability K+ efﬂux Hemolysis K+ efﬂux Histamine release
HR1 2 2 50 50–100 10 5
Polistes mastoparan 5 5 50 100–200 10 2–5
Vespula mastoparan 2–5 2–5 50 50–100 10–20 5–10
Granuliberin R 500 500 N500 N500 200–500 10
MCD peptide N50 N50 N200 N200 N50 0.05
Compound 48/80 100 50–100 N500 N500 10–20 0.5
Magainin I 10 10 N200 N200 20 10–20
Magainin II 5–10 5–10 N200 N200 20 10–20
Melittin 0.2–0.5 0.2–0.5 0.2–0.5 0.2–0.5 1–2 0.5
Gramicidin S 2–5 2–5 10 10 20 10–20
a ED50 values are shown in μM, except for compound 48/80 (μg/ml).
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human erythrocytes induced by compound 48/80 and its components,
at the same concentration (0.2 mg/ml). The monomer did not induce
marked changes in morphology at this concentration, probably due to
low partition in membranes. The dimer caused a change to the
invaginated form, indicating that it was preferentially incorporated
into the inner monolayer of the membrane by interacting with an
inner anionic phospholipid, because it was more lipophilic than the
monomer. However, the trimer suppressed the change to the
invaginated form, and moreover, 48/80 induced echinocytes to
form. These results indicated that the increased number of cationic
charges producing a strong hydrophilic nature made it difﬁcult for the
compounds to traverse the lipid interior. We expressed the dose-
dependence of the change in shape using morphological indices
deﬁned by Fujii and co-workers [39]. As shown in Fig. 8, the dimer
induced changes to the higher stages of the invaginated form with
increases in the concentration, while the trimer suppressed a change
in the invaginated form, and 48/80 induced morphological change in
the opposite direction, making echinocytes. Compound 48/80 inducedFig. 4. Granuliberin R-induced K+ efﬂux, cell viability, hemolysis, and histamine release
in (a) S. aureus cells, (b) erythrocytes, and (c) mast cells. The symbols used are the same
as those in Fig. 3.hemolysis (about 20%) at a concentration of 0.2 mg/ml. This feature
was similar to mastoparans, inducing hemolysis via echinocytes.
4. Discussion
In this study, we made potentiometric measurements with a K+-
selective electrode to analyze the actions of cationic amphiphilic
compounds on S. aureus cells, erythrocytes, and mast cells. The use of
an ion-selective electrode for biochemical analysis is attractive, because
the measurement is fast, easy, and continuous in a turbid cell
suspension. Hence, ion-selective electrodes have widely been applied
to the assay of membrane permeability [27,29,30,33,40–43]. For
analyzing changes in the permeability of cytoplasmic membranes of
living cells, the use of a K+-selective electrode is quite effective, because
K+ is present in the cytoplasmof all kinds of cells, and the permeability-
increasing action of biologically active substances in different cells can
be easily compared. A drawback is the relatively low sensitivity of the
electrodes which requires a high concentration of cells. With bacteria
and erythrocytes, it is easy to prepare a large number of cells; however,
formast cells, preparing large numbers is rather difﬁcult.We solved thisFig. 5. Compound 48/80-induced K+ efﬂux, cell viability, hemolysis, and histamine
release in (a) S. aureus cells, (b) erythrocytes, and (c) mast cells. The symbols used are
the same as those in Fig. 3.
Fig. 6. Changes in the morphology of human erythrocytes. (a) Intact cells. Cells were incubated with (b) HR1 (50 μM), (c) Polistesmastoparan (100 μM), or (d) Vespulamastoparan
(50 μM) at 37 °C for 30 min.
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the concentration of cells. This made it possible to perform 5–6
measurements from 106 mast cells, which could usually be collected
from the abdominal cavity of an individual rat.
Mastoparans generally exhibit a low hemolytic activity, but
relatively high antimicrobial activity [21]. All the mastoparans testedFig. 7. Changes in the morphology of human erythrocytes induced by compound 48 and its c
or (d) compound 48/80 at 37 °C for 30 min.in this study (HR1, Polistesmastoparan, and Vespula mastoparan) gave
just such results. Several characteristics of the peptides' actions should
be mentioned. First, all mastoparans increased the permeability of S.
aureus cells to K+, and decreased cell viability at similar concentrations,
supporting that the antimicrobial activity of mastoparans was attribut-
able to the increased permeability of the bacterial membrane. Second,onstituents. Cells were incubated at 200 μg/ml with (a) monomer, (b) dimer, (c) trimer,
Fig. 8. Changes in a morphological index as a function of the concentration of
compound 48 and its constituents. Erythrocytes were incubated with monomer (×),
dimer (○), trimer (Δ), or compound 48/80 (●) at 37 °C for 30 min.
496 S. Nakao et al. / Biochimica et Biophysica Acta 1808 (2011) 490–497mastoparansweremore effective in increasing the permeability ofmast
cells than erythrocytes. Because the release of histamine eventually
produced anegative charge inmast cells, the efﬂuxofK+ frommast cells
was observed after histamine's secretion. Third, the ﬁnding that the
concentrations required for the efﬂux of K+ from S. aureus cells were
much lower than those needed for the release of histamine indicates
that the mastoparans acted as antimicrobial agents rather than
histamine liberators. Antimicrobial peptides, magainin I and magainin
II, acted on bacteria andmast cells, similarly to themastoparans, though
these peptides were less effective against erythrocyte membranes than
mastoparans. Peptides acting strongly against both bacteria and
erythrocytes, such as melittin and gramicidin S, functioned at similar
concentrations. An interesting feature is that mastoparans and
magainins, whose antimicrobial activity was stronger than the
histamine-releasing activity, increased K+ efﬂux from mast cells, near
to the concentration causing histamine release. This indicated that the
membranolytic action of these peptides on mast cells was strong,
because of the high afﬁnity for anionic lipids. Indeed, Vespula
mastoparan has been reported to show a cytotoxic effect, due to the
permeabilizationof theplasmamembrane ofmast cells [51], similarly to
melittin [52]. Granuliberin R and MCD peptide acted much more
selectively as histamine liberators than themastoparans andmagainins.
These peptides could not interact with anionic lipids sufﬁciently to
permeabilize the membrane, probably because the separation between
the cationic and hydrophobic amino acid residues was insufﬁcient to
generate an effective amphiphilic structure in the molecules [53]. At
high concentrations, however, granuliberin R induced K+ efﬂux from
mast cells and bacterial cells, supporting the view that the peptide acted
on anionic lipids of not only bacterial cells but mast cells during
histamine secretion. Interestingly, compound 48/80, a potentially active
histamine liberator, is also a weak antimicrobial agent [46,47]. In fact,
compound 48/80 induced histamine release at very low concentrations,
while relatively high concentrations were required to induce the efﬂux
of K+ frombacteria. The concentration required for the efﬂux frommast
cells was signiﬁcantly lower than that needed for the efﬂux from
bacteria. This may be attributable to a difference in susceptibility to
compound 48/80 among anionicmembranes in different environments,
because the effects of amphiphilic compounds including 48/80 are
known to differ among bacteria, despite the bacterial cytoplasmic
membranes being generally rich in negatively charged lipids [5,26,47].
Summarizing the present results, we showed for the ﬁrst time that
histamine-releasing agents, also possessing antimicrobial activity,
caused the permeabilization of membranes in both bacteria and mast
cells.
We further investigated the morphological changes to human
erythrocytes induced by mastoparans. All the mastoparans caused achange from the normal discoid shape to a crenated form (echino-
cytes) at the concentrations causing hemolysis. In general, cationic
amphiphilic compounds caused invaginated forms named stomato-
cytes, as a result of electric interaction with phosphatidylserine that is
concentrated in the inner leaﬂet of the cytoplasmic membrane [49].
However, the hydrophilicity of cationic compounds is also known
to induce the formation of echinocytes, because of the reduced
permeability of the agents through the membrane interior [39,50].
There are several basic amino acids, such as lysine, and also acidic
amino acid, such as aspartic acid, in Polistes mastoparan, making it
strongly hydrophilic, and hence, the peptides predominantly accu-
mulated in the outer monolayer of the erythrocyte membrane,
forming echinocytes. To obtain further insight into the dependence
of cationic charges on cell shape, we used compound 48/80 and its
components (monomer, dimer, and trimer). The most active
constituent of compound 48/80 is reported to be the hexamer. Thus,
the cationic charges of the monomer, dimer, trimer, and compound
48/80 increased to +1, +2, +3, and +6, respectively. The monomer
did not induce marked changes in morphology, because of the low
activity to permeate the membrane. It is well established that
appropriate hydrophobicity is required to induce changes of shape
in erythrocytes [54,55]. The dimer caused a change to an invaginated
form. Because the dimer was more lipophilic than the monomer, it
could easily permeate the membrane, further traverse the lipid
interior, and reach the inside of the membrane by interacting with
anionic phospholipids that are concentrated in the inner half of the
membrane. The trimer suppressed the change to the invaginated
form, and 48/80 generated echinocytes. These results indicate that an
increase in cationic charge, enhancing hydrophilicity, made it difﬁcult
to cross the lipid interior. Compound 48/80 caused hemolysis after the
transformation of erythrocytes into echinocytes. Melittin and gram-
icidin S have also been reported to generate echinocytes at the
concentrations causing hemolysis [29].
Aside from the erythrocyte shape changes studied here, the effects
of antimicrobial peptides on bacterial membranes have been studied
extensively by electron microscopy. When magainin II was used at a
concentration where bacterial viability had decreased about 30%,
blebs were observed on the surface of the bacteria [56]. Melittin also
formed blebs on bacterial cells [57]. The formation of patches,
structurally similar to blebs, is observed after treatment with various
antimicrobial peptides [4,31]. The appearance of blebs or patches on
bacterial membranes seemed to be similar to the change to
echinocytes by human erythrocytes, as a result of the accumulation
of peptides on the outer surface of the cell membranes. Hence, these
results demonstrated that the breakdown of the biological mem-
branes including erythrocytes and bacteria proceeded as proposed by
the carpet model [4,31], accompanied by the accumulation of agents
at the outer surface.
5. Conclusion
In this study, histamine-releasing agents induced K+ efﬂux from
mast cells, dependent on their ability to cause K+ efﬂux from bacteria.
The present results explained how themembrane permeabilization of
mast cells by histamine-releasing agents correlated with their
antimicrobial abilities. Furthermore, we observed that mastoparans
changed the normal discoid shape of human erythrocytes to a
crenated form at the concentrations causing hemolysis. An experi-
ment using compound 48/80 and its components revealed that
increasing the cationic charge changed the erythrocytes into
echinocytes. Such changes correlated with blebs or patches formed
on bacterial membranes, as a result of the accumulation of peptides at
the outer surface of the cell membranes. The present results
supported that amphiphilic cationic peptides induced the breakdown
of biological membranes including erythrocytes as proposed by the
carpet model.
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